Stockreport

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Just Reported, And Analysts Assigned A US$11.67 Price Target [Yahoo! Finance]

Foghorn Therapeutics Inc.  (FHTX) 
PDF The early response was not positive, with shares down 2.1% to US$5.98 in the past week. Statutory results overall were mixed, with revenues coming in 31% lower than the [Read more]